Oxurion to participate in upcoming investor meetings

Leuven, be, boston, ma, us – march 31st, 2021 – 07.30 am cet – oxurion nv (euronext brussels: oxur), a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, today announces its management will participate and meet one on one with investors at the following upcoming virtual meetings:
BCYC Ratings Summary
BCYC Quant Ranking